Inpart monthly recap - September

Editor's picks

Review the most promising opportunities from our online partnering platform, Connect, hand-picked by our team. Request an introduction connect with the asset owners, share feedback to guide their development, or follow the project to get notified of future updates. Signup for the network here. ?

Bryoids for amyloid-related diseases

Biotech: Aphios Corporation

Scientists at Aphios have developed Bryoids , compounds that reduce amyloid plaques and promote synapse formation by targeting specific enzymes. Using advanced nanoencapsulation methods, they have enhanced Bryoids' delivery to the brain, improving efficacy and safety, with potential to treat Alzheimer's and other similar diseases. The researchers are seeking development partners, licensing, and investment.

Read the full technology summary

Biomaterials reducing dairy waste for a greener future?

University: Lappeenranta-Lahti University of Technology?

Carbon neutrality goals and rising milk production make waste management a critical challenge for the dairy industry, with 16% of milk discarded globally each year. Researchers at Lappeenranta-Lahti University of Technology have developed ultra-low-cost ionic liquids that dissolve both casein and cellulose to enable the creation of sustainable biofilms and biofibers from waste milk, with applications in textiles, packaging, and healthcare. The team is seeking partners for further development.??

Read the full technology summary ?

Connect Campaigns

Connect Campaigns leverage our global scientific network to address industrial R&D needs and priorities through partnerships.?The campaigns below are active, seeking the submission of research, assets, expertise, and technologies from academic groups, TTOs, and startups.

??

Sensing analytes in blood (anonymous)?

Deadline for submissions: 21st October

A leading cardiac surgery company is seeking technologies for sensing analytes in blood. They are particularly interested in solutions that can measure and monitor analytes flowing through an extracorporeal circulation system within a hospital setting.??

Read the full campaign brief

Rare genetic disease research (anonymous)

Deadline for submissions: 14th October

To advance research in rare genetic diseases, this company is seeking therapeutic strategies to address TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia.

Read the full campaign brief ?

Predictive in vitro assays for kidney retention by radioconjugates (AstraZeneca)

Deadline for submissions: 28th October

AstraZeneca is seeking partners to collaborate on the development of a high-throughput assay predicting kidney retention of radioconjugates through in vitro or organoid models.

Read the full campaign brief

New report

R&D trends and breakthrough innovations: Eye health

We recently published our latest R&D trends and breakthrough innovations report. Download it for exclusive insights into eye health R&D trends, an industry sentiment analysis, and breakthrough innovations receiving the most engagement from industry on Inpart Connect.

Download the report for free

Events

2024 Inpart UGM Summit?

In mid-September, we hosted a three-day summit in Lyon. This in-person event brought our community together to share best practices in BD operations, alliance management and scouting, building the foundations of an annual forum in partnering excellence.??

Session recordings and talking points from the key sessions will be shared in the coming weeks.??

Labiotech?

Current trends & innovations in 3D organoids

The market for 3D cell models is projected to skyrocket from $1.42 billion to $5.29 billion by 2032, fueled by their pivotal role in advancing disease research and drug development. Our Sartorius-sponsored report explores the groundbreaking impact of 3D organoids, highlighting their current impact on research across key therapeutic areas and providing a detailed analysis and discussion of their benefits, challenges, and future directions.

?Read the full article ?

Inpart is the trusted platform for scientific partnering. We provide solutions to facilitate, optimize, and track collaborations helping bring science to life.

Our online partnering network is used by over 17,000 scientists and decision-makers in industry and academia matched by their research priorities and interests.

Signup for our network to identify new research and assets seeking partners, and establish new contacts for potential and future collaborations.

Or, speak with our team about how our platforms can help optimize your alliance management, due diligence, and partnering operations.